Literature DB >> 25835575

Vaccines against influenza A viruses in poultry and swine: Status and future developments.

J Rahn1, D Hoffmann1, T C Harder1, M Beer2.   

Abstract

Influenza A viruses are important pathogens with a very broad host spectrum including domestic poultry and swine. For preventing clinical disease and controlling the spread, vaccination is one of the most efficient tools. Classical influenza vaccines for domestic poultry and swine are conventional inactivated preparations. However, a very broad range of novel vaccine types ranging from (i) nucleic acid-based vaccines, (ii) replicon particles, (iii) subunits and virus-like particles, (iv) vectored vaccines, or (v) live-attenuated vaccines has been described, and some of them are now also used in the field. The different novel approaches for vaccines against avian and swine influenza virus infections are reviewed, and additional features like universal vaccines, novel application approaches and the "differentiating infected from vaccinated animals" (DIVA)-strategy are summarized.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Chicken; Influenza virus vaccines; Novel developments; Swine

Mesh:

Substances:

Year:  2015        PMID: 25835575     DOI: 10.1016/j.vaccine.2015.03.052

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  13 in total

1.  Vaccination with virus-like particles containing H5 antigens from three H5N1 clades protects chickens from H5N1 and H5N8 influenza viruses.

Authors:  Darrell R Kapczynski; Terrence M Tumpey; Rachmat Hidajat; Aniko Zsak; Klaudia Chrzastek; Irina Tretyakova; Peter Pushko
Journal:  Vaccine       Date:  2016-02-08       Impact factor: 3.641

2.  MicroRNA-Based Attenuation of Influenza Virus across Susceptible Hosts.

Authors:  Louisa E Sjaastad; Jessica K Fiege; Barbara M Waring; Elizabeth J Fay; Ismarc Reyes; Branden Moriarity; Ryan A Langlois
Journal:  J Virol       Date:  2018-01-02       Impact factor: 5.103

3.  A new self-attenuated therapeutic influenza vaccine that uses host cell-restricted attenuation by artificial microRNAs.

Authors:  Ke Wen; Haiyan Wang; Yanping Chen; Huixiao Yang; Zhichao Zheng; Yongyong Yan; Adilene Realivazquez Pena; Mingtao Zeng
Journal:  Int J Pharm       Date:  2021-12-06       Impact factor: 5.875

4.  Preparation of quadri-subtype influenza virus-like particles using bovine immunodeficiency virus gag protein.

Authors:  Irina Tretyakova; Rachmat Hidajat; Garrett Hamilton; Noah Horn; Brian Nickols; Raphael O Prather; Terrence M Tumpey; Peter Pushko
Journal:  Virology       Date:  2015-11-02       Impact factor: 3.616

5.  Accurate characterization of the IFITM locus using MiSeq and PacBio sequencing shows genetic variation in Galliformes.

Authors:  Irene Bassano; Swee Hoe Ong; Nathan Lawless; Thomas Whitehead; Mark Fife; Paul Kellam
Journal:  BMC Genomics       Date:  2017-05-30       Impact factor: 3.969

Review 6.  Harnessing Local Immunity for an Effective Universal Swine Influenza Vaccine.

Authors:  Elma Tchilian; Barbara Holzer
Journal:  Viruses       Date:  2017-05-05       Impact factor: 5.048

7.  Multi-antigen avian influenza a (H7N9) virus-like particles: particulate characterizations and immunogenicity evaluation in murine and avian models.

Authors:  Che-Ming Jack Hu; Chu-Yang Chien; Ming-Tsan Liu; Zih-Syun Fang; Sui-Yuan Chang; Rong-Huay Juang; Shih-Chung Chang; Hui-Wen Chen
Journal:  BMC Biotechnol       Date:  2017-01-07       Impact factor: 2.563

8.  DNA vaccine based on conserved HA-peptides induces strong immune response and rapidly clears influenza virus infection from vaccinated pigs.

Authors:  Marta Sisteré-Oró; Sergi López-Serrano; Veljko Veljkovic; Sonia Pina-Pedrero; Júlia Vergara-Alert; Lorena Córdoba; Mónica Pérez-Maillo; Patrícia Pleguezuelos; Enric Vidal; Joaquim Segalés; Jens Nielsen; Anders Fomsgaard; Ayub Darji
Journal:  PLoS One       Date:  2019-09-25       Impact factor: 3.240

Review 9.  Challenges of influenza A viruses in humans and animals and current animal vaccines as an effective control measure.

Authors:  Sung J Yoo; Taeyong Kwon; Young S Lyoo
Journal:  Clin Exp Vaccine Res       Date:  2018-01-29

10.  AIV polyantigen epitope expressed by recombinant baculovirus induces a systemic immune response in chicken and mouse models.

Authors:  Lei Yu; Jun Pan; Guangli Cao; Mengsheng Jiang; Yunshan Zhang; Min Zhu; Zi Liang; Xing Zhang; Xiaolong Hu; Renyu Xue; Chengliang Gong
Journal:  Virol J       Date:  2020-08-05       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.